Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
BlackRock
New York
| $4.77B | -$333M | 86 | 0.1% | Reduced |
|
| 2 |
Vanguard Group
Malvern,
Pennsylvania
| $4.31B | -$40.3M | 82 | 0.08% | Reduced |
|
| 3 |
Fidelity Investments
Boston,
Massachusetts
| $2.5B | -$177M | 67 | 0.16% | Reduced |
|
| 4 |
State Street
Boston,
Massachusetts
| $1.92B | -$144M | 78 | 0.08% | Reduced |
|
| 5 |
Wellington Management Group
Boston,
Massachusetts
| $1.82B | +$10.9M | 24 | 0.35% | Increased |
|
| 6 |
Morgan Stanley
New York
| $1.49B | +$178M | 92 | 0.11% | Increased |
|
| 7 |
Dimensional Fund Advisors
Austin,
Texas
| $1.43B | +$127M | 39 | 0.35% | Increased |
|
| 8 |
Dodge & Cox
San Francisco,
California
| $1.32B | -$42.2M | 1 | 0.75% | Reduced |
|
| 9 |
Primecap Management
Pasadena,
California
| $1.24B | -$80.7M | 5 | 1.03% | Reduced |
|
| 10 |
Janus Henderson Group
London,
| $1.17B | -$66.1M | 19 | 0.64% | Reduced |
|
| 11 |
Geode Capital Management
Boston,
Massachusetts
| $1.05B | +$35.1M | 93 | 0.08% | Increased |
|
| 12 |
SVGI
Sozo Ventures GP II
Redwood City,
California
| $1.01B | $0 | 1 | 100% | Maintained |
|
| 13 |
UBS Group
Zurich,
Switzerland
| $998M | +$374M | 98 | 0.18% | Increased |
|
| 14 |
Bank of America
Charlotte,
North Carolina
| $940M | +$80.2M | 95 | 0.08% | Increased |
|
| 15 |
Goldman Sachs
New York
| $932M | +$183M | 66 | 0.15% | Increased |
|
| 16 |
GS
Gilead Sciences
Foster City,
California
| $870M | $0 | 4 | 73.64% | Maintained |
|
| 17 |
Capital International Investors
Los Angeles,
California
| $869M | -$58.1M | 4 | 0.17% | Reduced |
|
| 18 |
Franklin Resources
San Mateo,
California
| $855M | +$48M | 30 | 0.25% | Increased |
|
| 19 |
Fisher Asset Management
Camas,
Washington
| $808M | +$508M | 5 | 0.35% | Increased |
|
| 20 |
Viking Global Investors
Stamford,
Connecticut
| $762M | -$103M | 1 | 2.42% | Reduced |
|
| 21 |
Avoro Capital Advisors
New York
| $759M | +$14.7M | 6 | 11.85% | Increased |
|
| 22 |
Loomis, Sayles & Company
Boston,
Massachusetts
| $712M | +$17.9M | 4 | 1.03% | Increased |
|
| 23 |
RTW Investments
New York
| $696M | +$55.4M | 8 | 10.65% | Increased |
|
| 24 |
T. Rowe Price Associates
Baltimore,
Maryland
| $693M | -$60.7M | 46 | 0.09% | Reduced |
|
| 25 |
Invesco
Atlanta,
Georgia
| $685M | +$32.6M | 46 | 0.13% | Increased |
|